FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078679 [Registered on: 27/12/2024] Trial Registered Prospectively
Last Modified On: 28/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   EFFECT OF PUTIKADI LEPA AND SHVITRAHARA VARTI ALONG WITH SHASHILEKHA VATI IN VITILIGO. 
Scientific Title of Study   A RANDOMISED CLINICAL TRIAL ON COMPARATIVE EFFICACY OF PUTIKADI LEPA AND SHVITRAHARA VARTI COADMINISTERED WITH SHASHILEKHA VATI IN VITILIGO PATIENTS AND ITS IMPACT ON ALPHA-MSH. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  VINAY KUMAR 
Designation  MD SCHOLAR 
Affiliation  ALL INDIA INSTITUTE OF AYURVEDA, NEW DELHI 
Address  ROOM NO 311, 3RD FLOOR,ACADEMIC BLOCK,DEPARTMENT OF ROGA NIDANA EVUM VIKRITI VIGYANA ,ALL INDIA INSTITUTE OF AYURVEDA , GAUTAMPURI,SARITA VIHAR, NEW DELHI 110076
ROOM NO 311, 3RD FLOOR,ACADEMIC BLOCK,DEPARTMENT OF ROGA NIDANA EVUM VIKRITI VIGYANA ,ALL INDIA INSTITUTE OF AYURVEDA , GAUTAMPURI,SARITA VIHAR, NEW DELHI 110076
South
DELHI
110076
India 
Phone  9560743062  
Fax    
Email  vinay.bams99@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  VINAY KUMAR 
Designation  MD SCHOLAR 
Affiliation  ALL INDIA INSTITUTE OF AYURVEDA, NEW DELHI 
Address  ROOM NO 311, 3RD FLOOR,ACADEMIC BLOCK,DEPARTMENT OF ROGA NIDANA EVUM VIKRITI VIGYANA ,ALL INDIA INSTITUTE OF AYURVEDA , GAUTAMPURI,SARITA VIHAR, NEW DELHI 110076
ROOM NO 311, 3RD FLOOR,ACADEMIC BLOCK,DEPARTMENT OF ROGA NIDANA EVUM VIKRITI VIGYANA ,ALL INDIA INSTITUTE OF AYURVEDA , GAUTAMPURI,SARITA VIHAR, NEW DELHI 110076
South
DELHI
110076
India 
Phone  9560743062  
Fax    
Email  vinay.bams99@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr ANAND B MORE 
Designation  PROFESSOR OF ROGA NIDANA EVUM VIKRITI VIGYAN  
Affiliation  ALL INDIA INSTITUTE OF AYURVEDA 
Address  ROOM NO.311,3RD FLOOR ACADEMIC BLOCK,DEPARTMENT OF ROGA NIDANA EVUM VIKRITI VIGYAN ,ALL INDIA INSTITUTE OF AYURVEDA,GAUTAMPURI,SARITA VIHAR, NEW DELHI-110076 SOUTH DELHI 110076 INDIA
ROOM NO.311,3RD FLOOR ACADEMIC BLOCK,DEPARTMENT OF ROGA NIDANA EVUM VIKRITI VIGYAN ,ALL INDIA INSTITUTE OF AYURVEDA,GAUTAMPURI,SARITA VIHAR, NEW DELHI-110076 SOUTH DELHI 110076 INDIA
South
DELHI
110076
India 
Phone  9422025732  
Fax    
Email  drmoreanand@gmail.com  
 
Source of Monetary or Material Support  
ALL INDIA INSTITUTE OF AYURVEDA, GAUTAM PURI, SARITA VIHAR, NEW DELHI-110076  
 
Primary Sponsor  
Name  ALL INDIA INSTITUTE OF AYURVEDA 
Address  GAUTAMPURI,SARITA VIHAR NEW DELHI-110076 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR ANAND B MORE  ALL INDIA INSTITUTE OF AYURVEDA  OPD NO 16 SCREENING OPD HOSPITAL BLOCK GROUND FLOOR GAUTAMPURIPURI SOUTH DELHI NEW DELHI
South
DELHI 
09422025732

drmoreanand@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L80||Vitiligo. Ayurveda Condition: SVITRAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: SHWITRAHARA VARTI, Reference: ASHTANGA HRIDYA CHIKITSA 20/23, Route: Topical, Dosage Form: Lepa Churna, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: PUTIKADI LEPA, Reference: SUSHRUTA CHIKITSA 9/40, Route: Topical, Dosage Form: Lepa Churna, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  (1) Patients diagnosed with nonsegmental vitiligo with maximum 2 years of disease history.
(2) Patients of age group: 21-45 years of either gender.
(3) Patients willing to participate.
 
 
ExclusionCriteria 
Details  (1) Patients suffering from psychiatric illness.
(2) Pregnant females and lactating women.
(3) Patients suffering from any other Systemic Disorders like uncontrolled diabetes, hepatitis B positive, HIV positive, active case of tuberculosis, immunocompromised patient, kidney disease, other skin disease.
(4) Cases of vitiligo due to burns.
(5) Any allergic condition related to skin and hypersensitivity to any medicine.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
improvement in shwitra assessed through VETF and VASI score in vitiligo patients.  0th day and 60th day. 
 
Secondary Outcome  
Outcome  TimePoints 
change in level of Alpha-MSH at 0th to 60th day in blood samples of vitiligo patients  0th day to 60th day 
 
Target Sample Size   Total Sample Size="72"
Sample Size from India="72" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The clinical efficacy of Sashilekha Vati  and Shvitrahar Varti   are documented in  previous studies. However, no combination study of the two drugs is yet available.The ointment Putikadi Lepa[i] is a classical yoga mentioned in Sushruta Samhita 940 for Shvitra.No previous study on Putikadi Lepa in relation to Shvitra is yet available across various research databases, hence this drug was chosen to compare its effectiveness with Shvitrahar Varti through a clinical trial of 60 days.  
Close